Policies

DHA PI 6490.01: BH Treatment and Outcomes Monitoring

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (k): a. Establishes the Defense Health Agency’s (DHA) procedures for the collection and analysis of BH outcome data. b. Addresses how DoD will standardize BH outcome data collection to: assess variations in mental health and substance use care among in-garrison medical treatment facilities (MTFs) and clinics; assess the relationship of treatment protocols and practices to BH outcomes; and identify barriers to provider implementation of evidence-based clinical guidance approved by DoD. c. Designates the Army as the DoD lead Service for maintenance and sustainment of the Behavioral Health Data Portal (BHDP) in specialty care mental health and substance use clinics, referred to collectively as BH clinics, until BHDP functionality can be integrated with GENESIS or another electronic health record (EHR) system managed by DHA. d. Designates DHA Information Operations (J-6) as lead on transitioning BHDP functional requirements related to outcomes monitoring to future EHR data collection platforms and processes.

• Identification #: DHA PI 6490.01
• Date: 7/12/2018
• Type: DHA Procedural Instruction
• Topics: Mental Health Care | Substance Abuse

TRICARE Retail Refund DoD Pricing Agreement

This agreement satisfies the requirement of TRICARE regulation (32 CFR 199.21(q)(2)(i)) for a manufacturer’s written agreement and for establishing refund procedures (32 CFR 199.21(q)(3)(i)).

• Identification #: N/A
• Date: 7/9/2018
• Type: Guidelines
• Topics: N/A

Guidance for the 2018-2019 Annual Influenza Immunization Program

ASD(HA) memo detailing the forthcoming immunization requirements for the 2018-19 influenza season.

• Identification #: N/A
• Date: 7/6/2018
• Type: Memorandums
• Topics: Influenza Seasonal

CORRIGENDUM FOR “Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline”

This describes errors made in the original document, and summarizes the corrections made to the recommendations.

• Identification #: N/A
• Date: 7/2/2018
• Type: Memorandums
• Topics: Transgender Education References and Training Resources

UPDATE TO NOTIFICATION OF TEMPORARY CHANGE IN POLIO VACCINATION GUIDANCE FOR UNITED STATES AFRICA COMMAND (USAFRICOM) THEATER

• Identification #: N/A
• Date: 7/1/2018
• Type: Guidelines
• Topics: Polio

YELLOW FEVER VACCINATION REQUIREMENTS FOR THE US AFRICA COMMAND (USAFRICOM) THEATER (MODIFICATION 2 - EXCEPTION FOR ASCENSION ISLAND)

• Identification #: N/A
• Date: 7/1/2018
• Type: Guidelines
• Topics: Yellow Fever

DoDI 6000.11: PATIENT MOVEMENT

Establishes policy, assigns responsibilities, and defines roles for implementation of the DoD PM mission.

• Identification #: DoDI 6000.11: PATIENT MOVEMENT
• Date: 6/22/2018
• Type: Instructions
• Topics: N/A

DHA PI 6025.07: Naloxone in the MTFs

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h), establishes the Defense Health Agency’s (DHA) procedures for prescribing and dispensing naloxone by pharmacists in MTFs to eligible beneficiaries, upon beneficiary request, or when the pharmacist determines the beneficiary meets the established criteria for being at risk for a life-threatening opiate overdose.

• Identification #: DHA PI 6025.07
• Date: 6/19/2018
• Type: DHA Procedural Instruction
• Topics: Health Readiness | TRICARE Pharmacy Program

DHA PI 6025.04: Pain Management and Opioid Safety in the MHS

The purpose of our MHS Pain Management Campaign is to enable Clinical Communities to provide evidence-based pain management guided by clinical practice guidelines (CPGs): effectively treat acute and chronic pain; promote non-pharmacologic treatment; prevent acute pain from becoming chronic; and minimize use of opioids with appropriate prescribing only when indicated. The Pain Management Clinical Support Service achieves these ends through clinical improvements in pain care, clinician and patient education, and research. This Defense Health Agency-Procedural Instruction (DHA-PI) is a dual effort between the Pain Management Clinical Support Service and the Clinical Communities to achieve our stated purpose through implementation of the MHS Stepped Care Model.

• Identification #: DHA PI 6025.04
• Date: 6/8/2018
• Type: DHA Procedural Instruction
• Topics: TRICARE Pharmacy Program | Substance Abuse

DHA-IPM 18-004:Emergency Power and Standby Generators

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (i), establishes the Defense Health Agency’s (DHA) procedures for identifying when, where, and what type of emergency power and/or standby generators are acceptable and appropriate for use within the Military Healthy System, including medical treatment facilities (MTFs), medical research facilities, and research laboratories. This DHA-IPM is effectively immediately; it will be incorporated into a DHA-Procedural Instruction and will expire effective 12 months from the date of issue or when the DHA-Procedural Instruction is signed, whichever comes first.

• Identification #: N/A
• Date: 6/5/2018
• Type: DHA Interim Procedures Memorandum
• Topics: N/A

DHA PI 6025.06: Standardized Templates for Primary Care Clinical Encounter Documentation

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (d), establishes the Defense Health Agency’s (DHA) procedures for all DoD Medical Treatment Facilities (MTFs) providing healthcare services in the direct care system. In support of direct care system MTFs delivering a standard scope of primary care to all beneficiaries, clinicians will use standardized electronic entry forms for electronic health record systems. This is in compliance with Reference (d). Standardized templates supporting clinical practice guidelines, care pathways, and standardized workflow will be used for documenting all outpatient face-to-face encounters in primary care. Tri-Service Workflow (TSWF) adult and pediatric CORE forms will be used in Armed Forces Health Longitudinal Technology Application (AHLTA), and the equivalent forms within Military Health System (MHS) GENESIS.

• Identification #: DHA PI 6025.06
• Date: 5/16/2018
• Type: DHA Procedural Instruction
• Topics: N/A

DHA PI 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the procedures for the FHPQA Program as defined in Reference (z). This DHA-PI applies to: a. OSD, the Military Departments (including the United States Coast Guard (USCG) at all times, including when it is a Service in the Department of Homeland Security by agreement with that Department), the Office of the Chairman of the Joint Chiefs of Staff (CJCS) and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the DoD, the Defense Agencies, the DoD Field Activities, and all other organizational entities within the DoD (referred to collectively in this DHA-PI as the “DoD Components”). b. Civilian personnel, as defined in Reference (e), and DoD contractor personnel authorized to accompany the force (CAAF), in accordance with References (j), (m), and (n), respectively.

• Identification #: DHA PI 6200.05
• Date: 5/2/2018
• Type: DHA Procedural Instruction
• Topics: Health Readiness

DHA PI 6025.25: Military Health System (MHS) Drug Take Back (DTB) Program

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (g): - Describes procedures for MHS organizations to offer beneficiaries the option of returning their controlled and non-controlled prescriptions and over-the-counter medications for disposal through a DTB program. The DTB program will provide an environmentally safe method for beneficiaries to properly and safely remove unused and expired medications from circulation, including medications that can be used for suicide or suicide attempts and have the potential for misuse, diversion, or accidental poisoning. - Details the tasks and procedures necessary to ensure successful implementation of the MHS DTB program within military Medical Treatment Facilities (MTFs).

• Identification #: DHA PI 6025.25
• Date: 2/20/2018
• Type: DHA Procedural Instruction
• Topics: TRICARE Pharmacy Program | Drug Take Back Program

DHA TM 4165.01, Volume 2: Defense Medical Logistics Standard Support – Facilities Management (DMLSS-FM): Requirements Module

This Defense Health Agency-Technical Manual (DHA-TM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (h), establishes the Defense Health Agency’s (DHA) procedures for managing data in the Military Health System’s (MHS) Computer Aided Facility Management/Computerized Maintenance Management System (CAFM/CMMS) of record, DMLSS-FM.

• Identification #: 4165.01, Volume 2
• Date: 2/20/2018
• Type: DHA Technical Manual
• Topics: N/A

DHA PI 6025.03 DHA Publication System

Standard Processes and Criteria for Establishing Urgent Care (UC) Services and Expanded Hours and Appointment Availability in Primary Care in Medical Treatment Facilities (MTFs) to Support an Integrated Health Care System (IHCS)

• Identification #: DHA PI 6025.03
• Date: 1/30/2018
• Type: DHA Procedural Instruction
• Topics: N/A